Innovative Breakthrough in Cancer Treatment: MAIA's THIO-101
MAIA Biotechnology's THIO-101 shows 100% disease control in second-line non-small cell lung cancer patients, marking a significant advancement.
MAIA Biotechnology's THIO-101 shows 100% disease control in second-line non-small cell lung cancer patients, marking a significant advancement.